Stochastic Model of the Processe of the Spread of Platinum Drugs in Tumor Tissues
- Авторлар: Ginevsky D.A.1, Izhevskij P.V.1, Laschenova T.N.1
-
Мекемелер:
- A.I. Burnazyan Federal Medical Biophysical Center
- Шығарылым: Том 69, № 6 (2024)
- Беттер: 77-81
- Бөлім: Radiation Therapy
- URL: https://medbiosci.ru/1024-6177/article/view/363966
- DOI: https://doi.org/10.33266/1024-6177-2024-69-6-77-81
- ID: 363966
Дәйексөз келтіру
Толық мәтін
Аннотация
Purpose: The study of the kinetics of the spatio-temporal distribution of cisplatin, as an agent capable of increasing the effectiveness of chemo-radiation therapy of solid tumors.
Material and methods: The material was the data of literature on the results of experiments of various groups of authors who studied the content of platinum in tissues on biopsy materials. The method of simulation mathematical modeling (in silico) is used, based on the biological patterns of tumor growth, morphofunctional changes in the structure of tumor cells and tissues. Model is based on reaction-diffusion equation system, coefficients of which are random functions of space and time. The model takes into account the sequence of processes from intravenous administration of cisplatin and its spatial distribution in various tissues, until the excretion of its addicts from the cell.
Results: The heterogeneity of the distribution of the concentration of platinum atoms in the tumor is shown. Perhaps this is due to the varying degree of vascularization of tissues, the rate of metabolism of the tumor occurring in the outer layer and in its hypoxic core. These processes lead to significant errors when evaluating the biopsy data obtained in the experiments and the analysis of platinum content in the biopsy.
Conclusions: The calculation assessments of the distribution of platinum atoms in the tumor are consistent with the literature on the concentration of cisplatin in biopsy samples for carcinoma. The results of the calculations on the described model are fair, taking into account the morphological type, the size of the tumor and the plan of the administration of the drug. For other conditions (cancer types, treatment regimens, etc.), new calculations are necessary. To increase the efficiency of combined chemo-radiation therapy, cisplatin should be introduced at least 72 hours before the start of radiation therapy.
Негізгі сөздер
Авторлар туралы
D. Ginevsky
A.I. Burnazyan Federal Medical Biophysical Center
Email: dgin@oits.ru
Moscow
P. Izhevskij
A.I. Burnazyan Federal Medical Biophysical Center
Email: dgin@oits.ru
Moscow
T. Laschenova
A.I. Burnazyan Federal Medical Biophysical Center
Email: dgin@oits.ru
Moscow
Әдебиет тізімі
- Злокачественные новообразования в России в 2022 году (заболеваемость и смертность) / под ред. А.Д. Каприна и др. М.: МНИОИ им. П.А.Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2023. 275 с.
- Bucci М.К., Bevan A., Roach М. Advances in Radiation Therapy: Conventional to 3D, to IMRT, to 4D and Beyond // СA Cancer Clin. 2005. Vol.55. No.2. P.117–134.
- Сухих Е.С., Сухих Л.Г., Аникеева О.Ю., Ижевский П.В., Шейно И.Н. Дозиметрическая оценка различных методик сочетанной лучевой терапии больных раком шейки матки // Мед. радиология и радиационная безопасность. 2019. Т.64. №1. С.45–52. doi: 10.12737/article_5c55fb4a074ee1.27347494
- Дарьялова С.Л. и др. Использование противоопухолевых препаратов в качестве модификаторов реакции злокачественных опухолей на лучевую терапию // Современные тенденции развития лекарственной терапии опухолей. М., 1998. 76 с.
- Болотина Л.В., Владимирова Л.Ю., Деньгина Н.В., Новик А.В., Романов И.С. Практические рекомендации по лечению злокачественных опухолей головы и шеи // Злокачественные опухоли. 2016. №452. С. 55-63. doi: 10.18027/2224-5057-2016-452-55-63
- https://www.rlsnet.ru/drugs/cisplatin-ronc-58005 (дата обращения к сайту 25.05.2024).
- Гроховский С.Л., Зубарев В.Е. Специфическое расщепление 2-спиральной ДНК, индуцированное ионизацией атома платины рентгеновским облучением // Доклады Академии наук СССР. 1990. Т.313. № 6. С.1500-1504.
- Гиневский А.Ф., Гиневский Д.А., Ижевский П.В. Моделирование пространственно-временного распределения лекарственного агента в биологической ткани. Математическое моделирование. 2021. Т.33. №11. С. 3–17. doi: https://doi.org/10.20948/mm-2021-11-01
- Biston М.-С., Jouber A., Adam JF , Elleaume H., Bohic H., Charvet A.-M., Estève F., Foray N., Balosso J. Cure of Fisher Rats Bearing Radioresistant F98 Glioma Treated with cis-Platinum and Irradiated with Monochromatic Synchrotron X-Rays // Cancer Research. 2004. April 1. No.64. P.2317-2323.
- Zamboni WC, Gervais AC, Egorin MJ, Schellens JH, Hamburger DR, Delauter BJ, Grim A, Zuhowski EG, Joseph E, Pluim D, Potter DM, Eiseman JL. Inter- and Intratumoral Disposition of Platinum in Solid Tumors after Administration of Cisplatin // Clin Cancer Res. 2002. Sep. Vol.8. No.9. P.2992-9. PMID: 12231546.
- Цюши Ч. Конформационные изменения молекулы ДНК при взаимодействии с координационными соединениями платины и серебра: Дис. ... канд. физ.-мат. наук: 02.00.06. СПб., 2015. 120 с.
- Akaboshi M., Kawai K., Maki H., Akuta K., Ujeno У., Miyahara T. The Number of Platinum Atoms Binding to DNA, RNA and Protein Molecules of HeLa Cells Treated with Cisplatin at Its Mean Lethal Concentration // Jpn. J. Cancer Res. 1992. Мау. No.83. P. 522-526.
- Holding J.D., Lindup W.E., Bowdler D.A., Siodlak M.Z., Stell P.M. Disposition and Tumour Concentrations of Platinum in Hypoalbuminaemic Patients after Treatment with Cisplatin for Cancer of the Head and Neck // Br.J.Clin. Pharmac. 1991. Vol.32. P.173-179.
Қосымша файлдар
